1,743
Views
0
CrossRef citations to date
0
Altmetric
Systematic Review

Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literature

, , , , , & show all
Pages 65-76 | Received 16 Sep 2022, Accepted 16 Nov 2022, Published online: 27 Nov 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.